.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
US Army
Chubb
Harvard Business School
UBS
Novartis
QuintilesIMS
Cipla
Dow
Johnson and Johnson

Generated: December 13, 2017

DrugPatentWatch Database Preview

ENTECAVIR Drug Profile

« Back to Dashboard

When do Entecavir patents expire, and when can generic versions of Entecavir launch?

Entecavir is a drug marketed by Accord Hlthcare, Amneal Pharms, Aurobindo Pharma Ltd, Cipla Ltd, Hetero Labs Ltd V, Par Pharm Inc, Prinston Inc, Sandoz Inc, Teva Pharms Usa, and Zydus Pharms Usa Inc. and is included in ten NDAs.

The generic ingredient in ENTECAVIR is entecavir. There are sixteen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the entecavir profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Accord HlthcareENTECAVIRentecavirTABLET;ORAL205824-001Aug 25, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Teva Pharms UsaENTECAVIRentecavirTABLET;ORAL202122-002Aug 26, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Cipla LtdENTECAVIRentecavirTABLET;ORAL206872-001Dec 6, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Amneal PharmsENTECAVIRentecavirTABLET;ORAL206652-002Nov 12, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Par Pharm IncENTECAVIRentecavirTABLET;ORAL206294-002Nov 23, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa IncENTECAVIRentecavirTABLET;ORAL206745-002Jun 23, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Cipla LtdENTECAVIRentecavirTABLET;ORAL206872-002Dec 6, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa IncENTECAVIRentecavirTABLET;ORAL206745-001Jun 23, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sandoz IncENTECAVIRentecavirTABLET;ORAL206672-002May 11, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Prinston IncENTECAVIRentecavirTABLET;ORAL208782-002Oct 10, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
Accenture
US Department of Justice
McKesson
Fish and Richardson
Cerilliant
Dow
Queensland Health
Chubb
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot